1.92
price down icon2.54%   -0.05
after-market Handel nachbörslich: 1.90 -0.02 -1.04%
loading

Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
14.40%
4.3779
5.1146 3.115 3.4452 2.903
Income/Loss From Continuing Operations Before Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Income/Loss From Continuing Operations After Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Net Income/Loss
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Diluted Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Basic Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Diluted Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.33
price up icon 0.87%
$358.53
price up icon 0.23%
$218.42
price up icon 2.77%
$65.75
price up icon 2.85%
$118.22
price up icon 0.49%
$536.11
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):